Tempest Therapeutics Correlations

TPST Stock

USD 1.26 0.04 3.08%

The correlation of Tempest Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Tempest Therapeutics Correlation With Market

Very weak diversification

The correlation between Tempest Therapeutics and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tempest Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Tempest Stock please use our How to Invest in Tempest Therapeutics guide.

Moving together with Tempest Stock

0.68	DYAI	Dyadic International	Pair Corr
0.73	DNA	Ginkgo Bioworks Holdings	Pair Corr
0.84	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.84	PTN	Palatin Technologies Earnings Call Tomorrow	Pair Corr
0.9	LPCN	Lipocine	Pair Corr
0.73	MBIO	Mustang Bio	Pair Corr
0.81	ONCT	Oncternal Therapeutics	Pair Corr
0.84	RANI	Rani Therapeutics	Pair Corr
0.66	ABCL	Abcellera Biologics	Pair Corr

Moving against Tempest Stock

0.9	XGN	Exagen Inc	Pair Corr
0.87	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.81	SNY	Sanofi ADR	Pair Corr
0.71	REGN	Regeneron Pharmaceuticals	Pair Corr
0.57	SLS	Sellas Life Sciences	Pair Corr
0.52	BIAFW	BioAffinity Technologies	Pair Corr
0.49	SERA	Sera Prognostics	Pair Corr
0.44	APGE	Apogee Therapeutics,	Pair Corr
0.35	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.85	HCA	HCA Holdings	Pair Corr
0.81	AVTR	Avantor Sell-off Trend	Pair Corr
0.81	CPRX	Catalyst Pharmaceuticals	Pair Corr
0.8	ENSG	Ensign Group	Pair Corr
0.75	CNTA	Centessa Pharmaceuticals	Pair Corr
0.75	CAH	Cardinal Health	Pair Corr
0.64	EHC	Encompass Health Corp	Pair Corr
0.62	CALT	Calliditas Therapeutics	Pair Corr
0.61	DVA	DaVita HealthCare	Pair Corr
0.54	SMMT	Summit Therapeutics PLC Buyout Trend	Pair Corr

Related Correlations Analysis

	INDP	RZLT	CMRA	FBRX	SANA	OLMA	CGEM	LIFE	ZNTL	LYEL
INDP		-0.49	0.59	0.91	0.6	0.15	-0.04	0.33	0.6	0.64	INDP
RZLT	-0.49		-0.1	-0.43	-0.1	0.25	0.41	0.01	-0.08	-0.35	RZLT
CMRA	0.59	-0.1		0.4	0.15	-0.16	-0.18	0.11	0.72	0.45	CMRA
FBRX	0.91	-0.43	0.4		0.57	0.38	0.05	0.21	0.55	0.6	FBRX
SANA	0.6	-0.1	0.15	0.57		0.33	0.56	0.38	0.27	0.53	SANA
OLMA	0.15	0.25	-0.16	0.38	0.33		0.62	-0.14	0.35	0.24	OLMA
CGEM	-0.04	0.41	-0.18	0.05	0.56	0.62		0.09	0.16	0.12	CGEM
LIFE	0.33	0.01	0.11	0.21	0.38	-0.14	0.09		-0.05	0.05	LIFE
ZNTL	0.6	-0.08	0.72	0.55	0.27	0.35	0.16	-0.05		0.69	ZNTL
LYEL	0.64	-0.35	0.45	0.6	0.53	0.24	0.12	0.05	0.69		LYEL
	INDP	RZLT	CMRA	FBRX	SANA	OLMA	CGEM	LIFE	ZNTL	LYEL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FBRX	+ 0.91	INDP
ZNTL	+ 0.72	CMRA
LYEL	+ 0.69	ZNTL
LYEL	+ 0.64	INDP
CGEM	+ 0.62	OLMA
SANA	+ 0.6	INDP

High negative correlations

RZLT	- 0.49	INDP
FBRX	- 0.43	RZLT
LYEL	- 0.35	RZLT
CGEM	- 0.18	CMRA
OLMA	- 0.16	CMRA
LIFE	- 0.14	OLMA

Risk-Adjusted Indicators

There is a big difference between Tempest Stock performing well and Tempest Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tempest Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
INDP	2.89	(1.08)	0.00	(0.41)	0.00	0.00	5.74	(7.64)	21.41
RZLT	2.67	0.19	0.07	0.25	2.72	(3.17)	7.85	(4.96)	27.78
CMRA	5.99	(0.04)	0.00	(0.06)	0.00	0.00	13.95	(12.70)	30.28
FBRX	4.11	(0.65)	0.00	11.85	0.00	0.00	10.00	(8.94)	46.63
SANA	3.28	(0.64)	0.00	(0.14)	0.00	0.00	7.69	(7.44)	21.25
OLMA	3.18	(0.05)	0.02	0.08	4.51	(3.05)	6.83	(6.99)	25.94
CGEM	2.64	(0.13)	(0.01)	0.04	3.14	(2.89)	6.13	(5.47)	23.38
LIFE	2.57	0.46	0.10	(0.69)	2.62	(3.23)	6.45	(5.29)	28.98
ZNTL	4.59	(0.41)	0.00	(0.03)	0.00	0.00	11.41	(8.64)	24.84
LYEL	4.87	(0.58)	0.00	(0.07)	0.00	0.00	11.72	(8.59)	39.20

Tempest Therapeutics Corporate Management

Nicholas Maestas	VP Secretary	Profile
Dr Dubensky	Pres Director	Profile
Justin Trojanowski	Treasurer Controller	Profile
RAC Sakai	Head Quality	Profile
Samuel MD	Executive Officer	Profile
Petpiboon Prasit	Acting Director	Profile
Anne Moon	Project Leadership	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC